nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC5A8—Organic anion transporters—SLC5A5—bile duct cancer	0.131	0.254	CbGpPWpGaD
Niacin—HCAR3—pancreas—bile duct cancer	0.095	0.197	CbGeAlD
Niacin—NNMT—gall bladder—bile duct cancer	0.0768	0.159	CbGeAlD
Niacin—HCAR2—pancreas—bile duct cancer	0.0629	0.13	CbGeAlD
Niacin—QPRT—liver—bile duct cancer	0.0478	0.0989	CbGeAlD
Niacin—QPRT—Nicotinate metabolism—PTGS2—bile duct cancer	0.0456	0.0885	CbGpPWpGaD
Niacin—NNMT—pancreas—bile duct cancer	0.0354	0.0732	CbGeAlD
Niacin—SLC5A8—Amino acid and oligopeptide SLC transporters—SLC5A5—bile duct cancer	0.0307	0.0597	CbGpPWpGaD
Niacin—HCAR2—lymph node—bile duct cancer	0.0307	0.0635	CbGeAlD
Niacin—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—IDH2—bile duct cancer	0.0283	0.055	CbGpPWpGaD
Niacin—SLC16A3—pancreas—bile duct cancer	0.0242	0.05	CbGeAlD
Niacin—NNMT—liver—bile duct cancer	0.0225	0.0466	CbGeAlD
Niacin—SLC5A8—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.0181	0.0351	CbGpPWpGaD
Niacin—NNMT—lymph node—bile duct cancer	0.0173	0.0357	CbGeAlD
Niacin—SLC16A3—liver—bile duct cancer	0.0154	0.0318	CbGeAlD
Niacin—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—IDH2—bile duct cancer	0.0153	0.0297	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—SLC5A5—bile duct cancer	0.0128	0.0249	CbGpPWpGaD
Niacin—SLC16A3—lymph node—bile duct cancer	0.0118	0.0244	CbGeAlD
Niacin—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—IDH2—bile duct cancer	0.011	0.0213	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—TGFBR2—bile duct cancer	0.0103	0.0201	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—HGF—bile duct cancer	0.0095	0.0184	CbGpPWpGaD
Niacin—SLC16A1—liver—bile duct cancer	0.00934	0.0193	CbGeAlD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bile duct cancer	0.00871	0.0169	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00809	0.0157	CbGpPWpGaD
Niacin—SLCO2B1—liver—bile duct cancer	0.00804	0.0166	CbGeAlD
Niacin—QPRT—Metabolism—FAR2—bile duct cancer	0.00747	0.0145	CbGpPWpGaD
Niacin—SLC16A1—lymph node—bile duct cancer	0.00716	0.0148	CbGeAlD
Niacin—NNMT—Metabolism—FAR2—bile duct cancer	0.00695	0.0135	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—GNAS—bile duct cancer	0.0064	0.0124	CbGpPWpGaD
Niacin—SLCO2B1—lymph node—bile duct cancer	0.00616	0.0128	CbGeAlD
Niacin—HCAR3—G alpha (i) signalling events—GNAS—bile duct cancer	0.00607	0.0118	CbGpPWpGaD
Niacin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—IDH2—bile duct cancer	0.00593	0.0115	CbGpPWpGaD
Niacin—SLC22A5—liver—bile duct cancer	0.00534	0.011	CbGeAlD
Niacin—QPRT—Disease—RNF43—bile duct cancer	0.00436	0.00846	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00411	0.00798	CbGpPWpGaD
Niacin—SLC22A5—lymph node—bile duct cancer	0.00409	0.00847	CbGeAlD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00395	0.00767	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—GNAS—bile duct cancer	0.00388	0.00753	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—TGFB1—bile duct cancer	0.00387	0.00752	CbGpPWpGaD
Niacin—QPRT—Disease—IDH1—bile duct cancer	0.00375	0.00727	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—GNAS—bile duct cancer	0.00368	0.00714	CbGpPWpGaD
Niacin—QPRT—Metabolism—IDH2—bile duct cancer	0.00365	0.00708	CbGpPWpGaD
Niacin—CYP2D6—liver—bile duct cancer	0.00344	0.00713	CbGeAlD
Niacin—NNMT—Metabolism—IDH2—bile duct cancer	0.00339	0.00659	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—FAR2—bile duct cancer	0.00339	0.00659	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00319	0.0062	CbGpPWpGaD
Niacin—QPRT—Metabolism—IDH1—bile duct cancer	0.00314	0.00609	CbGpPWpGaD
Niacin—NNMT—Metabolism—IDH1—bile duct cancer	0.00292	0.00566	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—NRAS—bile duct cancer	0.00278	0.00539	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RNF43—bile duct cancer	0.00267	0.00518	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RNF43—bile duct cancer	0.00253	0.00491	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.0024	0.00466	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—KRAS—bile duct cancer	0.00239	0.00464	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—GNAS—bile duct cancer	0.00219	0.00426	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00213	0.00414	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—GNAS—bile duct cancer	0.00208	0.00403	CbGpPWpGaD
Niacin—QPRT—Metabolism—SLC5A5—bile duct cancer	0.00207	0.00402	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—HRAS—bile duct cancer	0.00203	0.00394	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00201	0.0039	CbGpPWpGaD
Niacin—QPRT—Disease—TGFBR2—bile duct cancer	0.00199	0.00387	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—GNAS—bile duct cancer	0.00199	0.00386	CbGpPWpGaD
Niacin—NNMT—Metabolism—SLC5A5—bile duct cancer	0.00192	0.00374	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—GNAS—bile duct cancer	0.00189	0.00366	CbGpPWpGaD
Niacin—QPRT—Disease—SMAD4—bile duct cancer	0.00188	0.00366	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00183	0.00356	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FAR2—bile duct cancer	0.00183	0.00356	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—GNAS—bile duct cancer	0.0018	0.0035	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HGF—bile duct cancer	0.00172	0.00333	CbGpPWpGaD
Niacin—Salicylic acid—PTGS2—bile duct cancer	0.0017	1	CrCbGaD
Niacin—SLC16A3—Metabolism—IDH2—bile duct cancer	0.00166	0.00322	CbGpPWpGaD
Niacin—QPRT—Metabolism—GNAS—bile duct cancer	0.00161	0.00312	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00156	0.00303	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—bile duct cancer	0.0015	0.00291	CbGpPWpGaD
Niacin—NNMT—Metabolism—GNAS—bile duct cancer	0.0015	0.0029	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—IDH1—bile duct cancer	0.00142	0.00277	CbGpPWpGaD
Niacin—QPRT—Disease—NOS2—bile duct cancer	0.0014	0.00272	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NOS2—bile duct cancer	0.00132	0.00255	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—bile duct cancer	0.00129	0.0025	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00122	0.00237	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFBR2—bile duct cancer	0.00122	0.00237	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GNAS—bile duct cancer	0.00118	0.00228	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFBR2—bile duct cancer	0.00116	0.00224	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SMAD4—bile duct cancer	0.00115	0.00224	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GNAS—bile duct cancer	0.00111	0.00216	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—bile duct cancer	0.0011	0.00213	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SMAD4—bile duct cancer	0.00109	0.00212	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00108	0.0021	CbGpPWpGaD
Niacin—QPRT—Disease—ERBB2—bile duct cancer	0.00105	0.00205	CbGpPWpGaD
Niacin—QPRT—Disease—PTGS2—bile duct cancer	0.00103	0.002	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—GNAS—bile duct cancer	0.000973	0.00189	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000948	0.00184	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SLC5A5—bile duct cancer	0.00094	0.00182	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000932	0.00181	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HGF—bile duct cancer	0.000926	0.0018	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—IDH2—bile duct cancer	0.000894	0.00174	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—bile duct cancer	0.000864	0.00168	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000842	0.00163	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—NRAS—bile duct cancer	0.000832	0.00161	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—bile duct cancer	0.000803	0.00156	CbGpPWpGaD
Niacin—QPRT—Disease—NRAS—bile duct cancer	0.000802	0.00156	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NRAS—bile duct cancer	0.000788	0.00153	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—IDH1—bile duct cancer	0.000769	0.00149	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—bile duct cancer	0.000758	0.00147	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—bile duct cancer	0.000753	0.00146	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—bile duct cancer	0.000746	0.00145	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—bile duct cancer	0.000731	0.00142	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GNAS—bile duct cancer	0.00073	0.00142	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000724	0.00141	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—bile duct cancer	0.000718	0.00139	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—bile duct cancer	0.000716	0.00139	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS2—bile duct cancer	0.00071	0.00138	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—bile duct cancer	0.000699	0.00136	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—bile duct cancer	0.000691	0.00134	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—bile duct cancer	0.000678	0.00132	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—bile duct cancer	0.000648	0.00126	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—bile duct cancer	0.000646	0.00125	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—bile duct cancer	0.000612	0.00119	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—bile duct cancer	0.000608	0.00118	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—bile duct cancer	0.000587	0.00114	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—bile duct cancer	0.000582	0.00113	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—bile duct cancer	0.000577	0.00112	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—bile duct cancer	0.000576	0.00112	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—bile duct cancer	0.000562	0.00109	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—bile duct cancer	0.000554	0.00108	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—bile duct cancer	0.000552	0.00107	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—bile duct cancer	0.000551	0.00107	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—bile duct cancer	0.000525	0.00102	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FAR2—bile duct cancer	0.00051	0.000991	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—bile duct cancer	0.000507	0.000985	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—bile duct cancer	0.000491	0.000954	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—bile duct cancer	0.000466	0.000904	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—bile duct cancer	0.000456	0.000886	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—bile duct cancer	0.000448	0.000869	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—bile duct cancer	0.000433	0.00084	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—bile duct cancer	0.000424	0.000824	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—bile duct cancer	0.000423	0.000821	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—bile duct cancer	0.000406	0.000789	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—bile duct cancer	0.000401	0.000778	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNAS—bile duct cancer	0.000394	0.000766	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—bile duct cancer	0.000392	0.000762	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—bile duct cancer	0.000378	0.000733	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—bile duct cancer	0.000376	0.00073	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—bile duct cancer	0.000359	0.000698	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—bile duct cancer	0.000356	0.000692	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—bile duct cancer	0.00035	0.000679	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—bile duct cancer	0.000344	0.000668	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—bile duct cancer	0.000341	0.000661	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—bile duct cancer	0.000326	0.000633	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—bile duct cancer	0.000311	0.000604	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—bile duct cancer	0.000297	0.000577	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH2—bile duct cancer	0.000249	0.000484	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH1—bile duct cancer	0.000214	0.000416	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—bile duct cancer	0.000212	0.000411	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—bile duct cancer	0.000141	0.000274	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNAS—bile duct cancer	0.00011	0.000213	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—bile duct cancer	5.9e-05	0.000115	CbGpPWpGaD
